We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+12.19%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$63.2B
AUM Growth
+$4.44B
(+7.5%)
Cap. Flow
-$400M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
37.48%
Holding
990
New
39
Increased
448
Reduced
439
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$105M |
| 2 |
Amazon
AMZN
|
+$95.9M |
| 3 |
Apple
AAPL
|
+$86.7M |
| 4 |
Walmart Inc
WMT
|
+$64.8M |
| 5 |
GE Aerospace
GE
|
+$48.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Southern Copper
SCCO
|
+$157M |
| 2 |
Tesla
TSLA
|
+$129M |
| 3 |
UnitedHealth
UNH
|
+$106M |
| 4 |
Fomento Económico Mexicano
FMX
|
+$103M |
| 5 |
Microsoft
MSFT
|
+$69.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.37% |
| 2 | Healthcare | 12.36% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Communication Services | 10.58% |
| 5 | Financials | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
iShares MSCI India Small-Cap ETF
SMIN
$750M
| $6.25M | 0.01% |
87,100
+66,654
| +326% | +$4.95M |
|
677
Kiniksa Pharmaceuticals
KNSA
$6.23B
| $6.16M | 0.01% |
+158,722
| New | +$5.16M |
|
678
MDU Resources
MDU
$4.18B
| $6.14M | 0.01% |
+345,598
| New | +$5.77M |
|
679
NeoGenomics
NEO
$1.99B
| $6.12M | 0.01% |
792,263
+379,165
| +92% | +$2.66M |
|
|
LENZ
680
LENZ Therapeutics
LENZ
$179M
| $6.09M | 0.01% |
130,726
+56,440
| +76% | +$2.08M |
|
681
Evergy
EVRG
$19.4B
| $6.08M | 0.01% |
79,924
+5,912
| +8% | +$421K |
|
682
InspireMD
NSPR
$31.4M
| $5.98M | 0.01% |
+2,481,117
| New | +$6.02M |
|
683
MP Materials
MP
$6.78B
| $5.88M | 0.01% |
86,233
-20,790
| -19% | -$1.31M |
|
684
Alliant Energy
LNT
$18.6B
| $5.8M | 0.01% |
86,099
-9,888
| -10% | -$638K |
|
685
Ionis Pharmaceuticals
IONS
$8.93B
| $5.75M | 0.01% |
87,924
-318,770
| -78% | -$15.6M |
|
|
HPP
686
Hudson Pacific Properties
HPP
$758M
| $5.75M | 0.01% |
300,638
| – | – |
|
687
Syndax Pharmaceuticals
SNDX
$1.7B
| $5.74M | 0.01% |
372,792
+69,366
| +23% | +$908K |
|
688
KE Holdings
BEKE
$17.7B
| $5.72M | 0.01% |
283,090
-36,234
| -11% | -$679K |
|
|
TECX
689
Tectonic Therapeutic
TECX
$536M
| $5.59M | 0.01% |
+356,176
| New | +$7.35M |
|
690
Veracyte
VCYT
$4.45B
| $5.56M | 0.01% |
162,102
-19,821
| -11% | -$569K |
|
691
Healthcare Realty
HR
$7.56B
| $5.5M | 0.01% |
309,928
+14,269
| +5% | +$241K |
|
692
Jabil
JBL
$30.1B
| $5.42M | 0.01% |
25,290
+6,651
| +36% | +$1.45M |
|
693
Hormel Foods
HRL
$14.2B
| $5.39M | 0.01% |
218,936
-77,569
| -26% | -$2.15M |
|
694
Franklin Resources
BEN
$16.8B
| $5.23M | 0.01% |
223,939
+13,195
| +6% | +$326K |
|
|
695
Fomento Económico Mexicano
FMX
$41.2B
| $5.18M | 0.01% |
52,135
-1,103,631
| -95% | -$103M |
|
696
American Homes 4 Rent
AMH
$12.1B
| $5.14M | 0.01% |
158,277
+32,675
| +26% | +$1.14M |
|
697
Infosys
INFY
$51B
| $5.06M | 0.01% |
310,141
-48,614
| -14% | -$837K |
|
698
Trade Desk
TTD
$8.97B
| $5.04M | 0.01% |
102,883
+27,672
| +37% | +$1.76M |
|
699
Fox Class B
FOX
$22.1B
| $4.95M | 0.01% |
86,467
+10,196
| +13% | +$538K |
|
700
ProQR Therapeutics
PRQR
$244M
| $4.9M | 0.01% |
2,298,823
+448,475
| +24% | +$980K |
|
Similar funds
Aberdeen Group's Q3 2025 Portfolio in Review
As of Q3 2025, Aberdeen Group held 990 positions worth $63.2B, up 7.5% from $58.8B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Aberdeen Group's Q3 2025 filing shows 39 new, 448 increased, 439 reduced and 38 closed positions. Its largest new stake was Hesai Group: 1,365,740 shares worth $38.2M. The largest sale was Southern Copper, an estimated $157M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Aberdeen Group's largest Q3 2025 buy was Hesai Group: 1,365,740 shares worth $38.2M.
- Aberdeen Group added most to Wells Fargo in Q3 2025, an estimated $105M increase.
- Aberdeen Group's biggest Q3 2025 reduction was Southern Copper, cutting an estimated $157M.
- Aberdeen Group fully exited Ansys in Q3 2025, selling an estimated $28.5M.
- Aberdeen Group's ten largest holdings make up 37% of its $63.2B portfolio in Q3 2025.
- Aberdeen Group opened 39 new positions and closed 38 in Q3 2025.
- Aberdeen Group's portfolio value rose 7.5% quarter-over-quarter to $63.2B.
Based on Aberdeen Group's 13F filing for Q3 2025, filed 7 Nov 2025.